Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF)
$ 35.89 +0.95 (+2.72%) Market Cap: 54.95 Bil Enterprise Value: 82.50 Bil PE Ratio: 0 PB Ratio: 1.15 GF Score: 77/100

Q3 2025 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Jan 30, 2025 / 10:30AM GMT
Release Date Price: $25.99 (+4.23%)

Jan 30, 2025 / 10:30AM GMT
Presentation
Jan 30, 2025 / 10:30AM GMT

=====================
Corporate Participants
=====================
* Christopher O'Reilly
Takeda Pharmaceutical Co Ltd - Global Head of Investor Relations
* Christophe Weber
Takeda Pharmaceutical Co Ltd - President, Chief Executive Officer, Representative Director
* Milano Furuta
Takeda Pharmaceutical Co Ltd - Chief Financial Officer, Director
* Andrew Plump
Takeda Pharmaceutical Co Ltd - President of Research & Development, Vice President of Subsidiary, Director

=====================
Conference Call Participants
=====================
* Steve Barker
Jefferies - Analyst
* Hidemaru Yamaguchi
Citi - Analyst
* Mike Nedelcovych
TD Cowen - Analyst
* Tony Ren
Macquarie - Analyst
* Shinichiro Muraoka
Morgan Stanley - Analyst
* Seiji Wakao
JPMorgan - Analyst
* Hiroshi Wada
SMBC Nikko - Analyst
* Miki Sogi
Bernstein - Analyst
* Fumiyoshi Sakai

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot